MedPath

RCT to evaluate effect of fibrin glue on seroma formation post MRM

Not Applicable
Conditions
Health Condition 1: C508- Malignant neoplasm of overlappingsites of breast
Registration Number
CTRI/2020/05/025011
Lead Sponsor
Maulana Azad Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All women with biopsy proven carcinoma breast undergoing modified radical mastectomy

Exclusion Criteria

1) Patients who received neoadjuvant chemoterapy or radiation to the breast/ axilla

2) Liver disease

3) History of coagulation disorder

4) Patients on anti coagulants

5) BMI > 35 kg/metre square

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Incidence of seroma formation <br/ ><br>2. Duration of drain in situ <br/ ><br>3. Total drain output till the time of drain removalTimepoint: During hospital stay and at 1 week, 2 weeks and 4 weeks from day of surgery
Secondary Outcome Measures
NameTimeMethod
1. Duration of hospital stay <br/ ><br>2. Surgical site infectionTimepoint: At 1 week, 2 weeks and 4 weeks from day of surgery
© Copyright 2025. All Rights Reserved by MedPath